Healthcare & Medical Devices Global On demand · 24-48h

Global Enema Market Strategic Research Report

Global Enema Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Enema Market
$1.51B2025
3.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Stimulant Type, Osmotic Type, Lubricant Type, Medicated Therapeutic Type

By Application: Constipation Treatment, Preoperative Bowel Preparation, Bowel Cleansing, Local Intestinal Inflammation Treatment, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Prestige Consumer Healthcare, Kenvue, Perrigo, Recordati, Casen Recordati, Nova Argentia, Ferring Pharmaceuticals, Coloplast, Wellspect HealthCare, Qufora, Hollister, Summit Pharmaceuticals, Alliance Labs, Health Chemical Pharmaceutical, Sato Pharmaceutical, Mune Pharmaceutical, Firson, Kyorin Pharmaceutical, Guangzhou Baiyunshan Jingxiutang Pharmaceutical, CordenPharma, Shenyang Hongqi Pharmaceutical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 147 pages
Market size 2025
$1.51B
Billion USD
Forecast CAGR
3.3%
2025-2032
Forecast 2032
$1.9B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Enema market size is predicted to grow from US$ 1,507 million in 2025 to US$ 1,889 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.

An enema is a liquid or semi-solid pharmaceutical preparation administered rectally into the colon for bowel evacuation, cleansing, or local drug therapy. Its mechanism of action includes stimulating intestinal peristalsis, softening stool, or increasing water content in the intestinal lumen through osmotic effects, thereby facilitating defecation or delivering medication. Common forms include small-volume ready-to-use enemas and large-volume cleansing enemas.

Upstream includes active pharmaceutical ingredients such as glycerin, phosphates, and lactulose, as well as excipients, medical-grade plastic containers, and packaging materials. Downstream applications include hospitals, primary healthcare institutions, and retail pharmacy channels. The overall industry gross margin generally ranges from 40% to 70%, with higher margins for branded and prescription products.

Global enema production is projected to reach 700 million units by 2025, with an average price of $2.2 per unit.

Global key Enema players cover Prestige Consumer Healthcare, Kenvue, Perrigo, Recordati, Casen Recordati, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Enema market?

What factors are driving Enema market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Enema market opportunities vary by end market size?

How does Enema break out by Type, by Application?

This report presents a comprehensive overview of the global Enema market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Stimulant Type
  • Osmotic Type
  • Lubricant Type
  • Medicated Therapeutic Type

Segment by Prescription Properties

  • Non-Prescription type
  • Prescription Type

Segment by Packaging

  • Ready-To-Use Bottle Type
  • Bag Type
  • Tube Type

Segment by Application

  • Constipation Treatment
  • Preoperative Bowel Preparation
  • Bowel Cleansing
  • Local Intestinal Inflammation Treatment
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Enema market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Constipation Treatment, Preoperative Bowel Preparation, Bowel Cleansing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Enema Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.51B
2025
Forecast
$1.9B
2032
CAGR
3.3%
2025–2032
Gebieden
5
global
Key companies
Prestige Consumer HealthcareKenvuePerrigoRecordatiCasen RecordatiNova ArgentiaFerring PharmaceuticalsColoplast
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Stimulant TypeOsmotic TypeLubricant TypeMedicated Therapeutic Type
By Application
Constipation TreatmentPreoperative Bowel PreparationBowel CleansingLocal Intestinal Inflammation TreatmentOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Stimulant Type
  • 3.1.3 Osmotic Type
  • 3.1.4 Lubricant Type
  • 3.1.5 Medicated Therapeutic Type
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Constipation Treatment
  • 4.1.3 Preoperative Bowel Preparation
  • 4.1.4 Bowel Cleansing
  • 4.1.5 Local Intestinal Inflammation Treatment
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Prestige Consumer Healthcare
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Kenvue
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Perrigo
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Recordati
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Casen Recordati
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Nova Argentia
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Ferring Pharmaceuticals
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Coloplast
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Wellspect HealthCare
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Qufora
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hollister
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Summit Pharmaceuticals
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Alliance Labs
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Health Chemical Pharmaceutical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sato Pharmaceutical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Mune Pharmaceutical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Firson
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Kyorin Pharmaceutical
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Guangzhou Baiyunshan Jingxiutang Pharmaceutical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 CordenPharma
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Shenyang Hongqi Pharmaceutical
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Enema market?
The global Enema market is estimated at US$ 1.51 billion in 2025 (base year) and is projected to reach US$ 1.89 billion by 2032.
How fast is the Enema market expected to grow?
The market is expected to grow at a CAGR of 3.3% from 2026 to 2032, expanding from US$ 1.51 billion in 2025 to US$ 1.89 billion in 2032, roughly 1.3 times its base-year value.
What does the Enema market cover?
An enema is a liquid or semi-solid pharmaceutical preparation administered rectally into the colon for bowel evacuation, cleansing, or local drug therapy. Its mechanism of action includes stimulating intestinal peristalsis, softening stool, or increasing water content in the intestinal lumen through osmotic effects, thereby facilitating defecation or delivering medication. Common forms include small-volume ready-to-use enemas and large-volume cleansing enemas.
What are the main segments of the Enema market by type?
By type, the market is segmented into Stimulant Type, Osmotic Type, Lubricant Type and Medicated Therapeutic Type.
Which applications drive demand in the Enema market?
Key applications covered include Constipation Treatment, Preoperative Bowel Preparation, Bowel Cleansing, Local Intestinal Inflammation Treatment and Others.
Who are the key players in the Enema market?
Key players profiled include Prestige Consumer Healthcare, Kenvue, Perrigo, Recordati, Casen Recordati, Nova Argentia, Ferring Pharmaceuticals and Coloplast, among 21 companies covered in total.
Which regions and countries are covered for Enema?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Enema market?
What factors are driving Enema market growth, globally and by region?
Who should buy the Enema market report?
The report is intended for manufacturers and solution providers, distributors and end users in Constipation Treatment, Preoperative Bowel Preparation and Bowel Cleansing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Enema market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.